Frontiers in Cell and Developmental Biology,
Journal Year:
2022,
Volume and Issue:
10
Published: April 20, 2022
Diabetic
kidney
disease
(DKD)
is
one
of
the
major
microvascular
complications
diabetes
mellitus,
with
relatively
high
morbidity
and
mortality
globally
but
still
in
short
therapeutic
options.
Over
decades,
a
large
body
data
has
demonstrated
that
oxidative
stress,
inflammatory
responses,
hemodynamic
disorders
might
exert
critical
influence
initiation
development
DKD,
whereas
delicate
pathogenesis
DKD
remains
profoundly
elusive.
Recently,
long
non-coding
RNAs
(lncRNAs),
extensively
studied
field
cancer,
are
attracting
increasing
attentions
on
mellitus
its
including
diabetic
retinopathy,
cardiomyopathy.
In
this
review,
we
chiefly
focused
abnormal
expression
function
lncRNAs
resident
cells
(mesangial
cell,
endothelial
podocyte,
tubular
epithelial
cell)
kidney,
summarized
roles
elaborated
their
potential
significance,
order
to
advance
our
knowledge
field,
which
help
future
research
clinical
treatment
for
disease.
Journal of Cellular and Molecular Medicine,
Journal Year:
2022,
Volume and Issue:
26(4), P. 1144 - 1155
Published: Jan. 9, 2022
Abstract
High
glucose
(HG)
is
one
of
the
basic
factors
diabetic
nephropathy
(DN),
which
leads
to
high
morbidity
and
disability.
During
DN,
expression
glomerular
transporter
1
(GLUT1)
increases,
but
relationship
between
HG
GLUT1
unclear.
Glomerular
mesangial
cells
(GMCs)
have
multiple
roles
in
HG‐induced
DN.
Here,
we
report
prominent
dysfunction,
especially
GMC
abnormalities,
DN
mice,
closely
related
alteration.
In
vivo
studies
shown
that
BBR
can
alleviate
pathological
changes
abnormal
renal
function
indicators
mice.
vitro,
(30,
60
90
μmol/L)
not
only
increased
proportion
G1
phase
also
reduced
S
under
conditions
at
different
times.
(60
significantly
PI3K‐p85,
p‐Akt,
p‐AS160,
membrane‐bound
cyclin
D1,
had
almost
no
effect
on
total
protein.
Furthermore,
declined
uptake
retarded
D1‐mediated
cell
cycle
arrest
phase.
This
study
demonstrated
inhibit
development
may
be
due
inhibiting
PI3K/Akt/AS160/GLUT1
signalling
pathway
regulate
proliferation
cycle,
supporting
as
a
potential
therapeutic
drug
for
ACS Omega,
Journal Year:
2024,
Volume and Issue:
9(14), P. 16358 - 16373
Published: March 29, 2024
To
explore
the
effect
of
periodontal
disease
on
progression
diabetic
kidney
(DKD),
to
observe
effects
artesunate
(ART)
intervention
and
tissues
in
type
1
rats
with
periodontitis,
possibility
ART
for
treatment
DKD.
Rat
models
diabetes
mellitus,
mellitus
periodontitis
were
established
through
streptozotocin
(STZ)
intraperitoneal
injection,
maxillary
first
molar
ligation,
P.
gingivalis
ligation
applied
sequentially.
Ten
weeks
after
modeling,
gavage
was
given
4
weeks.
Immunohistochemistry,
reverse
transcription-quantitative
polymerase
chain
reaction
(RT-qPCR),
Western
blot
used
investigate
inflammatory
factors,
fibrogenisis,
autophagy-related
proteins
tissues,
16S
rDNA
sequencing
detect
changes
dental
plaque
fluid
tissue
flora.
Compared
control
group,
protein
expression
levels
transforming
growth
factor
β1
(TGF-β1)
COL-IV
(PD)
group
increased.
The
TGF-β1,
Smad3,
increased
DM
+
PD
upregulated
group.
These
results
suggest
that
enhances
renal
fibrosis
this
process
is
related
TGF-β1/Smad/COL-IV
signaling
pathway.
Among
top
five
dominant
bacteria
abundance
Proteobacteria
most
significantly,
followed
by
Actinobacteria
Firmicutes
mild
increases.
relative
Proteobacteria,
Actinobacteria,
groups
also
showed
an
increasing
trend
compared
CON
trend,
which
may
mediate
increase
oxidative
stress
promote
occurrence
development
DN.
Periodontal
lead
imbalance
flora,
aggravate
damage
T1DM,
cause
glomerular
inflammation
tubulointerstitial
fibrosis,
reduce
level
autophagy.
delays
inhibiting
TGF-β-Smad
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: June 23, 2022
Background
Diabetic
nephropathy
(DN)
is
a
serious
complication
among
patients
with
diabetes.
Elucidating
its
pathogenesis
crucial
for
identifying
novel
biomarkers
and
therapeutic
targets
DN.
Methods
DN
tissues
were
harvested
examining
MALAT1,
LIN28A
Nox4.
Human
kidney-2
(HK-2)
cells
treated
high
glucose
(HG)
establishing
cell
model
of
Cell
viability
was
examined
by
MTT
assay.
HG-induced
apoptosis
secretion
TNF-α
IL-6
analyzed
TUNEL
ELISA
assays,
respectively.
RIP
RNA
pull-down
assays
applied
to
analyze
the
interaction
between
Nox4
in
HK-2
human
embryonic
kidney
293T
(HEK-293T)
cells.
A
rat
established
determine
role
MALAT1
vivo
.
Results
upregulated
HG-treated
Overexpression
or
reduced
enhanced
apoptosis,
ROS
generation
inflammatory
cytokines
cells,
whereas
knockdown
exerted
opposite
effects.
Furthermore,
directly
interacted
LIN28A.
Moreover,
facilitated
increase
stability.
Knockdown
relieved
injury
suppressing
AMPK/mTOR
signaling
alleviated
renal
tubular
epithelial
Nox4/AMPK/TOR
Conclusion
activates
via
interacting
stabilize
mRNA,
thereby
aggravating
glucose-induced
injury.
Our
findings
provide
potential
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 30, 2023
Diabetic
kidney
disease
(DKD)
is
a
common
microangiopathy
in
diabetic
patients
and
the
main
cause
of
death
patients.
The
manifestations
DKD
are
proteinuria
decreased
renal
filtration
capacity.
glomerular
rate
urinary
albumin
level
two
most
important
hallmarks
progression
DKD.
classical
treatment
controlling
blood
glucose
pressure.
However,
commonly
used
clinical
therapeutic
strategies
existing
biomarkers
only
partially
slow
roughly
predict
progression.
Therefore,
novel
methods,
targets
urgently
needed
to
meet
requirements.
In
recent
years,
increasing
attention
has
been
given
role
epigenetic
modification
pathogenesis
Epigenetic
variation
mainly
includes
DNA
methylation,
histone
changes
noncoding
RNA
expression
profile,
which
deeply
involved
DKD-related
inflammation,
oxidative
stress,
hemodynamics,
activation
abnormal
signaling
pathways.
Since
reversible
at
certain
stages,
it
valuable
identify
modifications
as
early
diagnosis
prevent
end-stage
(ESRD).
Because
current
understanding
mechanism
not
comprehensive,
purpose
this
review
summarize
occurrence
development
evaluate
value
therapies
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 27, 2023
Diabetic
kidney
disease
(DKD),
one
of
the
most
severe
complications
diabetes
mellitus
(DM),
has
received
considerable
attention
owing
to
its
increasing
prevalence
and
contribution
chronic
(CKD)
end-stage
(ESRD).
However,
use
drugs
targeting
DKD
remains
limited.
Recent
data
suggest
that
long
non-coding
RNAs
(lncRNAs)
play
a
vital
role
in
development
DKD.
The
lncRNA
H19
is
first
imprinted
gene,
which
expressed
embryo
down-regulated
at
birth,
tumors
been
subject
controversy,
however,
recent
years,
it
disease.
LncRNA
engaged
pathological
progression
DKD,
including
glomerulosclerosis
tubulointerstitial
fibrosis
via
induction
inflammatory
responses,
apoptosis,
ferroptosis,
pyroptosis,
autophagy,
oxidative
damage.
In
this
review,
we
highlight
research
on
molecular
mechanism
regulatory
forms
epigenetic,
post-transcriptional,
post-translational
regulation,
providing
new
predictive
marker
therapeutic
target
for
management
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: June 9, 2023
Diabetic
nephropathy
(DN)
is
a
serious
microvascular
complication
of
diabetes.
It
has
become
leading
cause
death
in
patients
with
diabetes
and
end-stage
renal
disease.
Ferroptosis
newly
discovered
pattern
programmed
cell
death.
Its
main
manifestation
the
excessive
accumulation
intracellular
iron
ion-dependent
lipid
peroxides.
Recent
studies
have
shown
that
ferroptosis
an
important
driving
factor
onset
development
DN.
closely
associated
intrinsic
(including
tubular
epithelial
cells,
podocytes,
mesangial
cells)
damage
Chinese
herbal
medicine
widely
used
treatment
DN,
long
history
definite
curative
effect.
Accumulating
evidence
suggests
can
modulate
cells
show
great
potential
for
improving
In
this
review,
we
outline
key
regulators
pathways
DN
summarize
herbs,
mainly
monomers
extracts,
target
inhibition
ferroptosis.
Frontiers in Cell and Developmental Biology,
Journal Year:
2025,
Volume and Issue:
13
Published: Feb. 18, 2025
Over-proliferation
of
mesangial
cells
(MCs)
is
one
the
main
pathological
changes
in
early
stages
diabetic
kidney
disease
(DKD).
Roxadustat,
an
oral
hypoxia-inducible
factor
(HIF)
prolyl
hydroxylase
inhibitor,
widely
studied
different
models
disease.
Whether
roxadustat
has
beneficial
effect
on
proliferation
MCs
and
DKD
remains
unknown.
The
optimal
concentration
for
inhibiting
MC
was
determined
using
CCK-8
colony
formation
assays.
Changes
cell
cycle
were
detected
flow
cytometry,
cycle-related
proteins
screened
quantitative
reverse
transcription
polymerase
chain
reaction.
Reverse
experiments
applied
Trp53-/-
line.
Co-immunoprecipitation
used
to
verify
interaction
between
HIF-1α
p53
predict
sites
interaction.
Finally,
a
corresponding
vivo
verification
performed.
Optimal
concentrations
high
glucose
(30
mM)
(100
μM)
established.
Roxadustat
showed
anti-proliferation
through
S-phase
arrest.
HIF-1α/p53/p21
downstream
cyclins
(cyclin
A1,
cyclin
A2,
E1)
changes.
A
experiment
confirmed
that
affected
p53,
co-immunoprecipitation
results
p53.
Molecular
docking
predicted
possible
Lys328,
Pro332,
Arg245,
Lys251
Ala222,
Tyr226,
Glu225,
Asp265
respectively.
animal
demonstrated
similar
db/db
mice.
regulates
inhibits
via
pathway.
This
may
be
potential
therapeutic
target
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 18, 2025
Diabetic
kidney
disease
(DKD)
is
the
leading
cause
of
end-stage
renal
(ESRD)
globally,
presenting
a
significant
therapeutic
challenge.
Extracellular
vesicles
(EVs)
from
mesenchymal
stem
cells
(MSCs)
have
emerged
as
promising
agents.
This
study
explored
effects
and
mechanisms
EVs
derived
human
placental
(hP-MSCs)
on
DKD.
were
isolated
cultured
hP-MSCs
administered
to
streptozotocin
(STZ)-induced
diabetic
mice
high
glucose–treated
glomerular
mesangial
cells.
The
impact
was
assessed
through
histological
analysis
biochemical
assays.
miR-99b-5p
expression
in
its
role
modulating
mechanistic
target
rapamycin
(mTOR)/autophagy
pathway
examined
via
western
blotting
RT‒qPCR.
Treatment
with
hP-MSC-derived
significantly
alleviated
fibrosis
improved
function
DKD
models.
These
enriched
miR-99b-5p,
which
targeted
inhibited
mTOR
signaling,
thereby
increasing
autophagic
activity
reducing
cellular
proliferation
extracellular
matrix
accumulation
tissues.
can
mitigate
injury
by
miR-99b-5p/mTOR/autophagy
pathway.
findings
suggest
potential
cell-free
strategy
for
managing
Journal of Inflammation Research,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 6077 - 6089
Published: May 1, 2025
Single
nucleotide
polymorphisms
(SNPs)
are
commonly
found
in
lncRNA,
and
can
regulate
its
expression.
The
study
examined
the
genotype
allele
distributions
of
rs9839776
polymorphism
lncRNA
SOX2OT
sepsis
patients
with
acute
kidney
injury
(AKI),
as
well
expression
changes.
function
AKI
cell
model
was
also
elucidated.
Serum
levels
were
via
qRT-PCR
450
septic
including
202
cases
248
without.
Genotyping
completed
Taqman
real-time
PCR.
HK-2
cells
treated
LPS
to
mimic
AKI,
viability,
apoptosis
inflammatory
response
evaluated
after
regulating
levels.
pathways
enriched
by
downstream
target
genes
explored
GO
KEGG
analysis.
Rs9839776
CC
carriers
observed
presented
reduced
SOX2OT.
lowly
expressed
patients,
which
distinguish
from
ones.
In
vitro,
alleviated
LPS-induced
mediating
proliferation,
response,
reversed
miR-9-5p.
analysis
uncovered
significant
links
miR-9-5p
cytoskeleton
muscle
cells,
adhesion
molecules
prolactin
signaling
pathway.
could
affect
susceptibility
for
its-mediated
downregulation
may
serve
a
biomarker
AKI.
underlying
mechanism
might
be
related
mediation
SOX2OT/miR-9-5p
axis.